IVAC W bre1 uID (BioNTech RNA Pharmaceuticals)

N/A

Report date: 2026/05/12 09:09:02

Base Information

Drug NameIVAC W bre1 uID (BioNTech RNA Pharmaceuticals)

Drug Alias NameIVAC_W_bre1_uIDBNT-114

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine > personalized mRNA cancer vaccinesVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwedenGermany

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesBiontech Se

China Registration ClassN/A

Develop Information

Active CompaniesBiontech Se

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A